New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 28, 2014
07:37 EDTAVGOAvago shares should be bought on weakness, says RBC Capital
Noting that Avago's stock has rallied significantly ahead of the company's Q2 results, RBC Capital recommends that investors buy the stock on any weakness. The firm thinks that expectations for the company's Q2 results are very high, but it keeps an $82 price target and Outperform rating on the shares.
News For AVGO From The Last 14 Days
Check below for free stories on AVGO the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 28, 2014
18:13 EDTAVGOOn The Fly: After Hours Movers
Subscribe for More Information
16:05 EDTAVGOAvago sees Q4 revenue up 18%-22%, consensus $1.42B
Subscribe for More Information
16:04 EDTAVGOAvago reports Q3 EPS $1.26, consensus $1.06
Subscribe for More Information
15:22 EDTAVGONotable companies reporting after market close
Subscribe for More Information
11:41 EDTAVGOAvago technical comments before earnings
The shares have outperformed most indexes in the last three months, trading up over 8%. Price is also very close to the 52-week high and life high at $77.21. On stronger than expected positive news and guidance, the life high would be an easy reach from current levels. Without overhead resistance, a next likely upside target would be at the $80 to $85 area depending on the degree of surprise. If the news is not as bullish as sentiment in the name supposes, there is greater risk of a strong downside risk given the big advance the stock has made. In the year-to-date period price is up over 44.6%. On an increasing scale of disappointment, the following support levels could be tested as downside objectives: $73.15, $69.38, and $67.52. The $70 area has been strong support in the last several months as shares consolidated gains. A breakdown below that level could therefore precipitate further price weakness.
August 27, 2014
07:34 EDTAVGOAvago Q3 results likely to beat expectations, says Oppenheimer
Subscribe for More Information
August 22, 2014
11:17 EDTAVGOPeregrine unlikely to receive competing bid, says Oppenheimer
Oppenheimer believes Peregrine (PSMI) is unlikely to receive a competing takeover bid to Murata's since Murata is Peregrine's largest customer and Avago (AVGO) and Skyworks (SWKS) are looking to diversify away from mobile. Opco thinks Murata may look to divest Peregrine's non-mobile business, and views Skyworks, RF Micro Devices (RFMD), Analog Devices (ADI), and M/A-Com Technology (MTSI) as logical buyers for the business.
August 21, 2014
17:00 EDTAVGOAvago files to sell $1B of 2% convertible senior notes due 2021
Subscribe for More Information
09:00 EDTAVGOSeveral semi companies have positive read through from deal, says Sterne Agee
After Infineon (IFNNY) bought International Rectifier (IRF), Sterne Agee thinks the deal indicates that the shares ofother players in the sector - including Spansion (CODE), NXP Semiconductors (NXPI), and Avago (AVGO) - can rise further. The firm keeps Buy ratings on the latter three stocks.
August 19, 2014
06:29 EDTAVGOMorgan Stanley remains a buyer of Avago
Subscribe for More Information
August 18, 2014
10:29 EDTAVGOGoldman cuts sector view on semiconductors to Cautious
Subscribe for More Information
08:04 EDTAVGOSemiconductors sector downgraded to Cautious from Neutral at Goldman
Goldman downgraded the Semiconductors sector to Cautious given signs the cycle is turning based on expectations for a slowdown in semiconductor revenue growth, above trend semi unit shipments that should normalize, and stretching lead times. As a result, the analyst sees risk to Q4 estimates and sees further downside of 10%-25% for the SOX (SOX) and downgraded NXP Semiconductors (NXPI) to Sell from Neutral, InvenSense (INVN) to Neutral from Buy, and removed Maxim Integrated (MXIM) from the Conviction Buy List.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use